FTY720 (Fingolimod) Sensitizes Prostate Cancer Cells to Radiotherapy by Inhibition of Sphingosine Kinase-1Dmitri Pchejetski, Olivier Cuvillier, Torsten Böhler et al.|Cancer Research|2010Cited by 146
Circulating sphingosine-1-phosphate and erythrocyte sphingosine kinase-1 activity as novel biomarkers for early prostate cancer detectionJoão Soares Nunes, Dmitri Pchejetski, Maria Naymark et al.|British Journal of Cancer|2012Cited by 57
Therapeutic Potential of Targeting SK1 in Human CancersHeba Alshaker, Dmitri Pchejetski, Lysann Sauer et al.|Advances in cancer research|2013Cited by 56
Sphingosine kinase 1 inhibition sensitizes hormone‐resistant prostate cancer to docetaxelLysann Sauer, Dmitri Pchejetski, Lenka Skalska et al.|International Journal of Cancer|2009Cited by 55
Circulating sphingosine-1-phosphate inversely correlates with chemotherapy-induced weight gain during early breast cancerDmitri Pchejetski, Justin Stebbing, João Soares Nunes et al.|Breast Cancer Research and Treatment|2010Cited by 7